On January 8, the FDA approved Farxiga (dapaglifozin) for the treatment of type 2 diabetes. The drug is called Forxiga in Europe, where it has been approved since...

(S)he said what!?

On April 3, an FDA Advisory Committee voted an overwhelming 13-1 in favor of approving MannKind’s ultra-rapid-acting inhaled insulin Afrezza for type 1 diabetes. The...

This November will be the third annual World Diabetes Day Postcard Exchange, where people from around the world will send and receive handmade postcards to celebrate...

On January 13, J&J LifeScan announced the launch of the OneTouch VerioSync blood glucose meter in the US. The meter sends blood glucose readings wirelessly (via...

We travel to Oregon to support test strip access for people with diabetes. Find out what transpired!

On April 17, Abbott announced a recall of the FreeStyle InsuLinx blood glucose meters due to software issues for readings of 1,024 mg/dl and above. The problem is...

In a whirlwind of diabetes news, a glimmer of hope for reducing diabetes complications.

The International Diabetes Federation (IDF) is holding the Take a Step for Diabetes campaign to increase awareness for diabetes. This “step” can be a variety of actions...

Eli Lilly announced in October the submission of dulaglutide, its once-weekly GLP-1 receptor agonist for type 2 diabetes, in the US and Europe. This means a regulatory...

How can you change bad habits and achieve your health goals? Adam offers ten tips for success.

We’re super proud to see our home city of San Francisco taking a stand against soda and sugary beverages and recognizing their role in the rising rates of obesity and...

On April 15, the FDA approved GlaxoSmithKline’s once-weekly GLP-1 agonist Tanzeum (albiglutide) for type 2 diabetes, which makes it the second once-weekly GLP-1 agonist...

On July 30, Ambio Health announced FDA clearance of its Remote Health Monitoring System , which can wirelessly send readings from the AgaMatrix Presto blood glucose...

On November 22, J&J/Janssen Cilags’ SGLT-2 inhibitor Invokana (canagliflozin) was approved in Europe. This makes Invokana the second SGLT-2 inhibitor approved in...

At the recent 2013 European Association for the Study of Diabetes (EASD) conference, Abbott debuted a new diabetes technology category called Flash Glucose Monitoring...

(S)he said what!?

On January 21, Glooko and Joslin announced a partnership to develop a new web/mobile-based diabetes management platform. The system will combine a “Virtual Joslin”...

Six inspiring lessons learned over the last decade at the Behavioral Diabetes Institute.

On March 25, Lilly and Boehringer Ingelheim (BI) announced that they submitted an application to the FDA for empagliflozin, an SGLT-2 inhibitor, for type 2 diabetes...